MAPT and Huntington disease: Furthermore, HD patients have lower concentrations of t-tau in the CSF in comparison to AD affected individuals, (96, 97, 209–212), and whether CSF t-tau levels truly reflect extracellular tau load in the central nervous system (CNS) of HD patients remains to be elucidated.